Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
Immunooncology (IO) drug development increasingly depends on understanding humanspecific immune mechanisms. However, these subtle, highly coordinated …
Read more
In the rapidly evolving landscape of oncology drug discovery, antibody-drug conjugates (ADCs) represent one of the most promising therapeutic modaliti…
Read more
Published in IBI on February 5, 2026, by Julie Ann Mayer, PhD
Read more
